美国食品药品监督管理局(FDA)批准兰特斯公司用于阿尔茨海默病评估的脑部成像剂

路透中文
Aug 14
<a href="https://laohu8.com/S/USFD">美国食品</a>药品监督管理局(FDA)批准兰特斯公司用于阿尔茨海默病评估的脑部成像剂

路透8月14日 - 兰特斯控股公司(Lantheus Holdings, LNTH.O)周五表示,美国食品和药物管理局已批准该公司的一种放射性制剂用于脑部扫描,以协助评估患者是否患有阿尔茨海默病。

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10